Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer
Clinical trial NCT07416994 · RECRUITING
Trial details
- NCT number
- NCT07416994
- Sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2028-08-31
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.